INS and cancer: This hypothesis is supported by the different ligand-binding ability of the isoforms (IR-A recognizes both insulin and IGF-2 with equal affinity, while IR-B primarily binds insulin), and by their diverse tissue distribution (IR-A is more expressed in fetal and cancer tissues, while IR-B is predominant in muscle, liver, and fat) (Figure 1A) (4).